Medicare’s drug pricing negotiations — the first of their kind in the United States, passed under President Joe Biden — face ...

The stock's fall snapped a two-day winning streak.

This double-digit growth in new drug sales showcases the company's ability to successfully commercialize cutting-edge ...

Novo Nordisk (NVO) and Eli Lilly's (LLY) weight loss drugs lead Evaluate Pharma’s list of best-selling drugs projected for ...

Bristol Myers Squibb is doubling down on a partnership with Medidata, signing a multiyear agreement to continue using the ...

Light Horse Therapeutics Inc., a developer of first-in-class small molecule therapeutics, today announced a $62 million Series A financing. The financing was led by founding investor Versant Ventures ...

Initial rounds of VC financing totaled $7.7 billion over 137 deals for biopharma in 2024, compared to $3.8 billion over 156 ...

Hyderabad: The queue of global pharma giants wanting to make Hyderabad their new home for drug discovery and tech centres is ...

The Biden administration’s justification of the first cycle of Medicare drug price negotiations is fueling curiosity and ...

Arjan van Manen joins BioLizard as Commercial Director, bringing over 20 years of commercial leadership experience in life sciencesMeet ...

Licensing deals have risen in prominence in a restrained market environment. Is it desperation, or an important part of the ...

The US Food and Drug Administration approved 50 new molecular entities in 2024 —just five fewer than it did in 2023. Last ...